Shield Therapeutics
June 16, 2025
Company Presentation
Multiple Therapeutics
Shield Therapeutics is a commercial stage specialty pharmaceutical company with a focus on addressing iron deficiency with its lead medicine ACCRUFeR®, a novel, stable, non-salt based oral therapy for adults with iron deficiency with or without anemia.
Company HQ City:
Wellesley
Company HQ State:
MA
Company HQ Country:
United States
Year Founded:
2008
Lead Product in Development:
ACCRUFeR
CEO
Anders Lundstrom
Development Phase of Lead Product
Multiple Products in Market
Exchange
AIM FTSE
Ticker
STX
When you expect your next catalyst update?
Pediatric population FDA and EMA decision
What is your next catalyst (value inflection) update?
H2 2025
Primary Speaker
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}